126 related articles for article (PubMed ID: 35681273)
21. Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review.
Yu WM; Li R; Sun BL; Du JK; Tuo HF
Int J Surg Case Rep; 2021 Dec; 89():106590. PubMed ID: 34784532
[TBL] [Abstract][Full Text] [Related]
22. Primary hepatic functional neuroendocrine tumor in an elderly female: Case report.
Kushwaha NK; Jaiswal P; Gupta P; Mishra N; Kulkarni SV
Clin Case Rep; 2024 Jan; 12(1):e8382. PubMed ID: 38161645
[TBL] [Abstract][Full Text] [Related]
23. PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma-paraganglioma origin.
Remes SM; Leijon H; Vesterinen T; Louhimo J; Pulkkinen V; Ezer S; Kere J; Haglund C; Arola J
APMIS; 2020 Nov; 128(11):563-572. PubMed ID: 32794589
[TBL] [Abstract][Full Text] [Related]
24. Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.
Panarelli N; Tyryshkin K; Wong JJM; Majewski A; Yang X; Scognamiglio T; Kim MK; Bogardus K; Tuschl T; Chen YT; Renwick N
Endocr Relat Cancer; 2019 Jan; 26(1):47-57. PubMed ID: 30021866
[TBL] [Abstract][Full Text] [Related]
25. [Primary cystic neuroendocrine tumor of the liver: case report].
Gamboa-Jiménez TI; Arreola-Rosales RL
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):505-509. PubMed ID: 30777419
[TBL] [Abstract][Full Text] [Related]
26. Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors: A retrospective study.
Jiao X; Luan W; Peng X; Liu L; Zhang L; Zhou L
Medicine (Baltimore); 2020 Dec; 99(51):e23655. PubMed ID: 33371100
[TBL] [Abstract][Full Text] [Related]
27. Genetics of neuroendocrine and carcinoid tumours.
Leotlela PD; Jauch A; Holtgreve-Grez H; Thakker RV
Endocr Relat Cancer; 2003 Dec; 10(4):437-50. PubMed ID: 14713256
[TBL] [Abstract][Full Text] [Related]
28. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
Lv Y; Han X; Xu XF; Ji Y; Zhou YH; Sun HC; Zhou J; Fan J; Lou WH; Huang C
BMC Cancer; 2019 Apr; 19(1):335. PubMed ID: 30961559
[TBL] [Abstract][Full Text] [Related]
29. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
30. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review.
Xia Y; Zhang L; Wu H; Qiao L; Xia L
J Int Med Res; 2020 Jun; 48(6):300060520932114. PubMed ID: 32589085
[TBL] [Abstract][Full Text] [Related]
31. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Klöppel G
Virchows Arch; 2022 Feb; 480(2):359-368. PubMed ID: 34499237
[TBL] [Abstract][Full Text] [Related]
32. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
[TBL] [Abstract][Full Text] [Related]
33. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
34. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
35. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
36. The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors.
Furnari M; Buda A; Delconte G; Citterio D; Voiosu T; Ballardini G; Cavallaro F; Savarino E; Mazzaferro V; Meroni E
J Gastrointestin Liver Dis; 2017 Jun; 26(2):151-156. PubMed ID: 28617885
[TBL] [Abstract][Full Text] [Related]
37. Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors.
Lai JP; Mertens RB; Mirocha J; Koo J; Venturina M; Chung F; Mendez AB; Kahn M; Dhall D
Endocr Pathol; 2015 Mar; 26(1):54-62. PubMed ID: 25433656
[TBL] [Abstract][Full Text] [Related]
38. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
[TBL] [Abstract][Full Text] [Related]
39. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract][Full Text] [Related]
40. O
Watanabe H; Yamazaki Y; Fujishima F; Izumi K; Imamura M; Hijioka S; Toriyama K; Yatabe Y; Kudo A; Motoi F; Unno M; Sasano H
BMC Cancer; 2020 Dec; 20(1):1195. PubMed ID: 33287738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]